Módulo 2

Tratamiento y pronóstico



20.- Kwon C. Jacoby A. Ali A et al (2022) Systematic review of frequency of felt and enacted stigma in epilepsy and determining factors and attitudes toward persons living with epilepsy. Report from the International League Against Epilepsy Task Force on Stigma in Epilepsy. Epilepsia. 2022;00:1–25.

21.- Narbona J.(2014). Fenomenología depresiva al inicio de enfermedades psiquiátricas. Rev neurology; 58 (Supl1): 571-575.

22.- Asociación Americana de psiquiatría (2014) Manual diagnóstico y estadístico de los trastornos mentales DSM-V, (5a ed), Editorial médica panamericana.

23.- Salinas J.(2012) Capítulo Epilepsia y depresión. Neurología Pediátrica.

24.- Zalaquett D. (2012) Capítulo Anamnesis psiquiátrica en la entrevista neurológica. Neurología Pediátrica.

25.- Brodie M J. Kwan P (2002) Staged approach to epilepsy management. Neurology 23;58(8 Suppl 5):S2-8.

26.- Gabel S and Saikaly D. (2001) Psychiatric Manifestations of Epilepsy in Children and Adolescents, Rev Neurology; 3:321–332.

27.- Bergey, G. K. (2016). Management of a First Seizure. Continuum: Lifelong Learning in Neurology, 22(1, Epilepsy), 38–50.

28.- Anthony, et al. (1995) Looking to the Future in Psychiatric Epidemiology, Rev. Epidemiol Rev.;17:240-242.

29.- Kessler, et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry,;51:8-19.

30.- Costello EJ.(1989)Developments in child psychiatric epidemiology. J Am Acad Child Adolesc Psychiatry;28:836-841.

31.- Weissman, et al.(1986) The Undertreatment of Anxiety: Overcoming the Confusion and Stigma, Journal Clinical Psychopharmacology. 1986;Suppl 6:11-17.